209 related articles for article (PubMed ID: 21475008)
1. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.
Gertler R; Stein HJ; Langer R; Nettelmann M; Schuster T; Hoefler H; Siewert JR; Feith M
Ann Surg; 2011 Apr; 253(4):689-98. PubMed ID: 21475008
[TBL] [Abstract][Full Text] [Related]
2. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
3. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
4. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
[TBL] [Abstract][Full Text] [Related]
5. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
[TBL] [Abstract][Full Text] [Related]
6. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
8. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
[TBL] [Abstract][Full Text] [Related]
11. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
14. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
19. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
20. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
Yang Q; Cleary KR; Yao JC; Swisher SG; Roth JA; Lynch PM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
Dis Esophagus; 2004; 17(1):38-43. PubMed ID: 15209739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
